Table 3: Within the group comparison of outcome measures in both groups.
Outcome measures |
Study groups |
Baseline |
4 weeks |
12 weeks |
24 weeks |
VAS |
Intervention (PRP) |
7.31 ± 0.79 |
4.94 ± 0.772 |
3.00 ± 0.730 |
0.88 ± 0.719 |
p value* |
0.00 |
||||
Control (Corticosteroid) |
7.38 ± 0.71 |
1.75 ± 0.775 |
1.69 ± 0.479 |
4.25 ± 1.125 |
|
p value* |
0.00 |
||||
SANE |
Intervention (PRP) |
35.31 ± 6.94 |
48.44 ± 7.89 |
63.44 ± 6.51 |
90.12 ± 6.05 |
p value* |
0.00 |
||||
Control (Corticosteroid) |
33.13 ± 6.02 |
75.63 ± 8.13 |
79.69 ± 6.70 |
61.63 ± 6.29 |
|
p value* |
0.00 |
||||
Quick DASH |
Intervention (PRP) |
73.75 ± 7.18 |
51.88 ± 8.34 |
30.63 ± 7.27 |
7.50 ± 5.77 |
p value* |
0.02 |
||||
Control (Corticosteroid) |
69.38 ± 8.92 |
23.13 ± 6.29 |
20.18 ± 6.32 |
24.14 ± 10.14 |
|
p value* |
0.03 |
*Repeated measures ANOVA; p-value < 0.05 is taken as significant